BioLife Solutions, Inc. (BLFS)
NASDAQ: BLFS · IEX Real-Time Price · USD
15.86
+0.72 (4.76%)
At close: Apr 18, 2024, 4:00 PM
16.20
+0.34 (2.14%)
After-hours: Apr 18, 2024, 4:53 PM EDT
BioLife Solutions Market Cap
BioLife Solutions has a market cap or net worth of $718.46 million as of April 18, 2024. Its market cap has decreased by -14.39% in one year.
Market Cap
718.46M
Enterprise Value
709.42M
1-Year Change
-14.39%
Ranking
Category
Stock Price
$15.86
Market Cap Chart
Since December 1, 1998, BioLife Solutions's market cap has increased from $4.30M to $718.46M, an increase of 16,608.33%. That is a compound annual growth rate of 22.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2024 | 685.80M | -5.38% |
| Apr 16, 2024 | 724.80M | 2.04% |
| Apr 15, 2024 | 710.30M | -4.98% |
| Apr 12, 2024 | 747.50M | -3.50% |
| Apr 11, 2024 | 774.60M | -0.93% |
| Apr 10, 2024 | 781.90M | -4.95% |
| Apr 9, 2024 | 822.60M | 4.91% |
| Apr 8, 2024 | 784.10M | 1.04% |
| Apr 5, 2024 | 776.00M | -2.17% |
| Apr 4, 2024 | 793.20M | 1.10% |
| Apr 3, 2024 | 784.60M | -1.59% |
| Apr 2, 2024 | 797.30M | -1.68% |
| Apr 1, 2024 | 810.90M | -3.50% |
| Mar 28, 2024 | 840.30M | 0.49% |
| Mar 27, 2024 | 836.20M | 1.99% |
| Mar 26, 2024 | 819.90M | -3.72% |
| Mar 25, 2024 | 851.60M | 0.96% |
| Mar 22, 2024 | 843.50M | 1.97% |
| Mar 21, 2024 | 827.20M | 1.96% |
| Mar 20, 2024 | 811.30M | 1.53% |
| Mar 19, 2024 | 799.10M | 3.77% |
| Mar 18, 2024 | 770.10M | -1.85% |
| Mar 15, 2024 | 784.60M | 0.35% |
| Mar 14, 2024 | 781.90M | -1.98% |
| Mar 13, 2024 | 797.70M | 5.77% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HealthStream | 747.51M |
| Cullinan Oncology | 745.90M |
| Evolus | 741.05M |
| Disc Medicine | 738.70M |
| ALX Oncology Holdings | 726.70M |
| Aurinia Pharmaceuticals | 723.09M |
| Nurix Therapeutics | 720.06M |
| Atrion | 720.05M |